Between 2015 and 2020, over 200 AI/ML-enabled medical devices received regulatory approval in the US and EU, with a strong focus on diagnostics and radiology.
Several of these innovations have already achieved reimbursement status, signaling a shift toward widespread adoption. One notable example covered by Puls Biznesu, one of Poland’s most prominent business publications, is BrainScan AI. This Gdańsk-based startup, led by Szymon Korzekwa, PhD, has developed an AI system to assist radiologists with the analysis of head CT scans. The tool has gained recognition and is currently being piloted in hospital settings.
These developments demonstrate how AI is transforming medical diagnostics—from niche prototypes to reimbursed, clinically meaningful solutions. At Axcellant, we continue to closely monitor these trends and explore how AI-powered tools can enhance imaging quality, trial efficiency, and ultimately, patient care.
Read more in the Puls Biznesu article (in Polish).
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant